Jianshuai Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianshuai Jiang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- An Wang
Department of General Surgery, Ningbo First Hospital, Ningbo, 315000, Zhejiang, China
1 shared publication Dongen Li
Department of General Surgery Ningbo First Hospital Ningbo China
1 shared publicationLiang Yang
Department of General Surgery Ningbo First Hospital Ningbo China
1 shared publicationXiaofeng Chen
Department of General Surgery Ningbo First Hospital Ningbo China
1 shared publication
Latest Publications
- Open Access
- 16 August 2021
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (9) , e23931
METTL3‐mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis
Background: Abnormal spindle‐like microcephaly (ASPM) has been proved to participate in tumor progression. However, the underlying mechanism of ASPM in liver hepatocellular carcinoma (LIHC) remains elusive.Methods: The mRNA and protein expression were determined using Western blot and qRT‐PCR, and the capacities of cells proliferation, migration, and invasion were evaluated by CCK‐8, colony formation, wound healing, and transwell. MeRIP was performed to validate the interaction between ASPM and methyltransferase‐like 3 (METTL3).Results: Herein, we found that ASPM was significantly upregulated in LIHC, and the high expression of ASPM was associated with poor LIHC prognosis. Furthermore, ASPM knockdown could suppress LIHC cells proliferation, migration, and invasion, while ASPM overexpression exerted reverse effect. Mechanistically, we revealed that the N6‐methyladenosine (m6A) modification of ASPM mRNA mediated by METTL3 promoted its expression in LIHC. More importantly, silencing METTL3 suppressed LIHC cells proliferation, migration, and invasion, which could be retained by ASPM overexpression.Conclusion: Collectively, our findings suggested that METTL3/ASPM axis could serve as a novel promising therapeutic candidate for LIHC.
- 16 August 2021
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (9) , e23931
Open AccessMETTL3‐mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis
Background: Abnormal spindle‐like microcephaly (ASPM) has been proved to participate in tumor progression. However, the underlying mechanism of ASPM in liver hepatocellular carcinoma (LIHC) remains elusive.Methods: The mRNA and protein expression were determined using Western blot and qRT‐PCR, and the capacities of cells proliferation, migration, and invasion were evaluated by CCK‐8, colony formation, wound healing, and transwell. MeRIP was performed to validate the interaction between ASPM and methyltransferase‐like 3 (METTL3).Results: Herein, we found that ASPM was significantly upregulated in LIHC, and the high expression of ASPM was associated with poor LIHC prognosis. Furthermore, ASPM knockdown could suppress LIHC cells proliferation, migration, and invasion, while ASPM overexpression exerted reverse effect. Mechanistically, we revealed that the N6‐methyladenosine (m6A) modification of ASPM mRNA mediated by METTL3 promoted its expression in LIHC. More importantly, silencing METTL3 suppressed LIHC cells proliferation, migration, and invasion, which could be retained by ASPM overexpression.Conclusion: Collectively, our findings suggested that METTL3/ASPM axis could serve as a novel promising therapeutic candidate for LIHC.